TP53 and neoplasm: p53 mutations not only impair the tumor suppressive functions of its wild-type but also acquire oncogenic functions, so-called gain-of-function (GOF), and contribute to the malignant characteristics, such as aggressiveness, invasiveness and chemoresistance [6].